The most important financial indicators for the company Novo Medica Srl - Unique Identification Number 14556406:
sales in 2023 was
301.241
euro, registering a net profit of
64.376
euro and having an average number of
6
employees.
Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala specializata having the NACE code 8622.
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded.
In the last year of activity, the sales increased by 1.5%, from 297.645 euro in the year 2022, to 301.241 euro in 2023.
The Net Profit increased by 3.356 euro, from 61.206 euro in 2022, to 64.376 in the last year.
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Novo Medica Srl - CUI 14556406
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Fixed Assets
133.761
126.931
330.945
314.937
402.040
394.815
378.813
403.863
397.757
380.947
Current Assets
19.013
24.508
31.282
80.861
33.098
38.501
18.508
26.926
64.459
116.655
Inventories
83
0
0
0
0
54
0
6.028
1.697
7.659
Receivables
0
1.793
11.403
567
1.716
2.521
1.559
7.045
5.019
13.099
Cash
18.930
22.715
19.879
80.294
31.382
35.926
16.949
13.853
57.743
95.896
Shareholders Funds
45.406
69.145
102.513
160.914
219.572
290.657
304.502
373.937
414.958
448.964
Social Capital
134
135
134
131
129
126
124
121
122
121
Debts
108.016
83.186
260.463
234.884
216.019
143.491
92.819
56.969
47.440
48.710
Income in Advance
0
0
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
4.4821
Main CAEN
"8622 - 8622"
CAEN Financial Year
8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
116.655 euro in 2023 which includes Inventories of
7.659 euro, Receivables of
13.099 euro and cash availability of
95.896 euro.
The company's Equity was valued at
448.964 euro, while total Liabilities amounted to
48.710 euro.
Equity increased by 35.264 euro, from 414.958 euro in 2022, to 448.964 in 2023.
Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Novo Medica Srl